Finance

Beta
Ask
Lists
VTGN:NASDAQ
Vistagen Therapeutics Inc
$0.67
-2.87%
(-0.020) 1D
$0.67
+0.46% (+0.0031)
After hours
Closed: Jun 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTGN...
Open
$0.69
High
$0.73
Low
$0.67
Mkt. cap
27.50M
Avg. vol.
1.02M
Volume
1.09M
52-wk high
$5.14
52-wk low
$0.43
EPS
-$1.90
Beta
0.32
Shares outstanding
41.03M
No. of employees
41
Open
$0.69
High
$0.73
Low
$0.67
Mkt. cap
27.50M
Avg. vol.
1.02M
Volume
1.09M
52-wk high
$5.14
52-wk low
$0.43
EPS
-$1.90
Beta
0.32
Shares outstanding
41.03M
No. of employees
41
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to VTGN in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for VTGN in the last 3 months.
Highest
Current $0.67
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
News stories
From sources across the web
About Vistagen Therapeutics Inc
CEO-
Employees41
Founded1998
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitevistagen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
244.00K
258.00K
303.00K
465.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.68M
15.92M
14.22M
13.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.37M
4.40M
5.63M
4.12M
Operating expense
16.05M
20.31M
19.85M
17.18M
Total operating expenses
16.05M
20.31M
19.85M
17.18M
Operating income
-15.80M
-20.05M
-19.55M
-16.72M
Other non operating income
-2.00K
6.00K
-
-2.00K
EBT including unusual items
-15.10M
-19.42M
-18.90M
-16.27M
EBT excluding unusual items
-15.10M
-19.42M
-18.90M
-16.27M
Income tax expense
-
-
-
7.00K
Effective tax rate
-
-
-
-0.04%
Other operating expenses
-
-
-
-
Net income
-15.10M
-19.42M
-18.90M
-16.27M
Net profit margin
-6,186.48%
-7,525.97%
-6,237.29%
-3,499.78%
Earnings per share
-0.47
-0.54
-0.45
-0.37
Interest and investment income
711.00K
630.00K
647.00K
452.00K
Interest expense
-
-
-
-
Net interest expenses
711.00K
630.00K
647.00K
452.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.76M
-20.00M
-19.49M
-16.66M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer